Gene and Cell Therapy Data Safety Monitoring Board that the 14-patient Phase I portion of the Company's ALLSTAR Phase I/II clinical trial has met its safety endpoints and that the Company is now cleared to begin the Phase II portion of the ALLSTAR clinical trial .
http://www.hispanicbusiness.com/2013/12/24/capricor_therapeutics_cleared_to_begin_phase.htm
http://www.hispanicbusiness.com/2013/12/24/capricor_therapeutics_cleared_to_begin_phase.htm
No comments:
Post a Comment